Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Frederick J.H. Whiting
Observed names:
Freddie Whiting,
Frederick J. H. Whiting,
Frederick JH. Whiting,
Frederick Whiting
Institutions:
Institute of Cancer Research,
Queen Mary University of London,
Barts Cancer Institute
Observed institutions:
Institute of Cancer Research,
Queen Mary University of London,
Institute of Cancer Research,
Barts Cancer Institute
ORCID:
0000-0003-4090-7136
Observed ORCID:
0000-0003-4090-7136
OpenAlex ID:
A5109655916
Phenotypic noise and plasticity in cancer evolution
2023
·
Frederick J.H. Whiting
, Jacob Househam
, et al.
·
Trends in Cell Biology
·
55
Adaptation repeatedly uses complex structural genomic variation
2025
·
Zachariah Gompert
, Jeffrey L. Feder
, et al.
·
Science
·
44
Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
·
Cancer Discovery
·
25
PDF
Quantitative measurement of phenotype dynamics during cancer drug resistance evolution using genetic barcoding
2025
·
Frederick J. H. Whiting
, Maximilian Mossner
, et al.
·
Nature Communications
·
15
Mathematical modelling of cancer cell evolution and plasticity
2025
·
Chloé Colson
, Frederick JH. Whiting
, et al.
·
Current Opinion in Cell Biology
·
10
Plasticity in metastatic colorectal cancer
2025
·
Frederick J.H. Whiting
, Trevor A. Graham
·
Developmental Cell
·
3
Tracing the evolutionary trajectory of CDK4/6 inhibitor resistance in oestrogen receptor positive breast cancer
2025
·
Rachael Natrajan
, Ioanna Mavrommati
, et al.
·
Research Square
·
1
PDF
Single cell multi-omic whole genome sequencing and chromatin accessibility profiling reveals genome-epigenome coevolution in colorectal cancer
2025
·
Maximilian Mossner
, Chloé Colson
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Inference of Cancer Drug Cross Resistance Using Only Single-Drug Exposure Data
2026
·
Frederick J.H. Whiting
, Ioanna Mavrommati
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Supplementary Table 7 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 9 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 3 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Figures S1-S17 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 5 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 10 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 4 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 6 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 8 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 2 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Note on Modelling 1 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Figure 4 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 2 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Supplementary Table 9 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Figure 2 from Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer
2026
·
William C.H. Cross
, Salpie Nowinski
, et al.
Show more works
View as search
Works count:
38
Citation count:
154
H-index:
5
I10-index:
5
Year
Topic
Type